N-[3-[3-cyclopentyl-5-(4-propan-2-ylphenyl)imidazol-4-yl]-5-fluoro-4-pyridinyl]furan-2-carboxamide
C27H27FN4O2 — CID 176637920
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[3-cyclopentyl-5-(4-propan-2-ylphenyl)imidazol-4-yl]-5-fluoro-4-pyridinyl]furan-2-carboxamide
N-[3-[3-cyclopentyl-5-(4-propan-2-ylphenyl)imidazol-4-yl]-5-fluoro-4-pyridinyl]furan-2-carboxamide (PubChem CID 176637920) has the molecular formula C27H27FN4O2 and a molecular weight of 458.54 g/mol. Its IUPAC name is N-[3-[3-cyclopentyl-5-(4-propan-2-ylphenyl)imidazol-4-yl]-5-fluoro-4-pyridinyl]furan-2-carboxamide.
Molecular Properties
| Compound Name | N-[3-[3-cyclopentyl-5-(4-propan-2-ylphenyl)imidazol-4-yl]-5-fluoro-4-pyridinyl]furan-2-carboxamide |
|---|---|
| PubChem CID | 176637920 |
| Molecular Formula | C27H27FN4O2 |
| Molecular Weight | 458.54 g/mol |
| Exact Mass | 458.21 |
| IUPAC Name | N-[3-[3-cyclopentyl-5-(4-propan-2-ylphenyl)imidazol-4-yl]-5-fluoro-4-pyridinyl]furan-2-carboxamide |
| SMILES | CC(C)c1ccc(-c2ncn(C3CCCC3)c2-c2cncc(F)c2NC(=O)c2ccco2)cc1 |
| InChI | InChI=1S/C27H27FN4O2/c1-17(2)18-9-11-19(12-10-18)24-26(32(16-30-24)20-6-3-4-7-20)21-14-29-15-22(28)25(21)31-27(33)23-8-5-13-34-23/h5,8-17,20H,3-4,6-7H2,1-2H3,(H,29,31,33) |
| InChIKey | FUSFVEUIIUPIGU-UHFFFAOYSA-N |
| XLogP | 6.84 |
| TPSA | 72.95 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 458.54 |
| LogP ≤ 5 | 6.84 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176637920 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.